Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
Belantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study
Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Eirini Solia, Panagiotis Malandrakis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Magdalini Migkou, Evangelos Eleutherakis Papaiakovou, Despina Fotiou, Giorgos Psarros, Efstathios Kastritis, Meletios A Dimopoulos (2025). Belantamab Mafodotin plus Lenalidomide/Dexamethasone in Newly Diagnosed Patients with Multiple Myeloma: Long-Term Efficacy and Safety Results from the Phase 1/2 BelaRd Study. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)03784-x.
Article67 days agoMM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)02604-7.
Article67 days agoEnhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0)
Floris Chabrun, Daniel L. Schwartz, Susanna Gentile, K. Elias, Tulika Gupta, Jacqueline Perry, David M. Cordas dos Santos, Thomas Hielscher, Annika Werly, Silke Schmidt, Foteini Theodorakakou, Despina Fotiou, Christine‐Ivy Liacos, Nikolaos Kanellias, Noelia Collado Gisbert, Esperanza Martín‐Sánchez, Rosalinda Termini, Johannes M. Waldschmidt, Selina J Chavda, Louise Ainley, Matteo Da Vià, Claudio De Magistris, Loredana Pettine, Michael Timonian, Jean-Baptiste Alberge, Vidhi Patel, Patrick Costello, Christine M. Tobia, Sem H. Phan, Jennifer Lamb, Mauro Nicollas Oliveira Silvério, Maya Davis, Elizabeth O’Donnell, Catherine R. Marinac, Omar Nadeem, Niccolò Bolli, Kwee Yong, K. Martin Kortüm, Hermann Einsele, María‐Victoria Mateos, Shaji Kumar, Jesús F. San Miguel, Bruno Paiva, Efstathis Kastritis, Meletios A Dimopoulos, Marc S. Raab, Lorenzo Trippa, Irene M. Ghobrial (2025). Enhanced Risk Stratification of Smoldering Multiple Myeloma with Dynamic Biomarkers: A Multinational, Multicenter Study including 2,270 Participants (PANGEA 2.0). , DOI: https://doi.org/10.21203/rs.3.rs-6696313/v1.
Preprint67 days agoPOSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). POSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)01259-5.
Article67 days agoPatterns of minimal residual disease trajectories in 323 newly diagnosed patients with multiple myeloma and correlation with progression-free survival
Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Sotirios Manganas, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Vasiliki Spiliopoulou, Magdalini Migkou, Despina Fotiou, Foteini Theodorakakou, Efstathios Kastritis, Maria Gavriatopoulou, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos (2025). Patterns of minimal residual disease trajectories in 323 newly diagnosed patients with multiple myeloma and correlation with progression-free survival. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-2216.
Article67 days ago